跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
蔡 同堯
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0001-9592-3278
電子郵件
11325
s.tmu.edu
tw
h-index
29
引文
3
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2025
每年研究成果
概覽
指紋
網路
研究成果
(9)
類似的個人檔案
(6)
指紋
查看啟用 Tung-Yao Tsai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Dizziness
100%
Phosphotransferase
100%
Manikin
100%
Laryngoscope
100%
Traumatic Brain Injury
100%
Nicotine Withdrawal
100%
Multilevel Analysis
100%
Endoscopic Therapy
100%
Risk Behavior
100%
Meta Analysis
100%
Mortality Rate
90%
Fatality
75%
Intubation
60%
Bougie
60%
Videolaryngoscope
60%
Bleeding
60%
Medline
40%
Logistic Regression Analysis
36%
Confidence Interval
31%
Biological Marker
28%
Blood Level
28%
Diseases
28%
Chi Square Test
25%
Adverse Event
25%
Prevalence
22%
Clinical Skill
20%
Endotracheal Tube
20%
Tracheal Intubation
20%
Medical Student
20%
Accident Prevention
20%
Neoplasm
20%
Embase
20%
Ligation
20%
Cochrane Library
20%
Upper Gastrointestinal Bleeding
20%
Endoscopic Submucosal Dissection
20%
Area under the Curve
14%
Nervous System Injury
14%
Receiver Operating Characteristic
14%
Protein Tyrosine Kinase
14%
Coma
14%
Patient Care
14%
Rat
14%
Odds Ratio
11%
Drug Therapy
11%
Education
11%
Medicine and Dentistry
Intubation
100%
Dizziness
100%
Traumatic Brain Injury
100%
Phosphotransferase
100%
X Chromosome
100%
Manikin
100%
Tracheal Intubation
33%
Prospective Study
33%
Tracheal Tube
33%
Medical Student
33%
Biological Marker
28%
Diseases
28%
Protein Tyrosine Kinase
14%
Patient Care
14%
Nervous System Injury
14%
Coma
14%
Area under the Curve
14%
Clinical Symptom
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acetic Acid Derivative
100%
Antroquinonol
100%
Cetuximab
100%
Lenvatinib
100%
Liver Cell Carcinoma
100%
Colorectal Carcinoma
100%
Western Blot
33%
Neoplasm
24%
Mouse Model
24%
Drug Resistance
24%
Caspase 3
16%
Caspase
16%
Initiation Factor 2
16%
Tumor Growth
16%
Antrodia camphorata
16%
Cell Viability
16%
Epidermal Growth Factor Receptor
15%
Carcinogenesis
15%
Therapeutic Effect
7%
Sulforhodamine B
7%
Carcinogenicity
7%
